Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 2566
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
ADENURIC 80MG TBL FLM 42 II
0208442 EU/1/08/447/015 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 80MG TBL FLM 56 II
0208443 EU/1/08/447/016 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 80MG TBL FLM 98 II
0208444 EU/1/08/447/018 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 120MG TBL FLM 28 II
0208445 EU/1/08/447/020 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 120MG TBL FLM 98 I
0167687 EU/1/08/447/012 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 120MG TBL FLM 56 I
0167686 EU/1/08/447/011 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 120MG TBL FLM 42 I
0167685 EU/1/08/447/010 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 120MG TBL FLM 84 I
0500259 EU/1/08/447/004 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 80MG TBL FLM 98 I
0167683 EU/1/08/447/008 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 80MG TBL FLM 56 I
0167682 EU/1/08/447/007 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 80MG TBL FLM 42 I
0167681 EU/1/08/447/006 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 80MG TBL FLM 14 I
0167680 EU/1/08/447/005 adenuric.pdf adenuric.pdf M04AA03 R
ADENURIC 120MG TBL FLM 42 II
0208448 EU/1/08/447/021 adenuric.pdf adenuric.pdf M04AA03 R
ADROVANCE 70MG/2800IU TBL NOB 4
0027978 EU/1/06/364/002 adrovance.pdf adrovance.pdf M05BB03 R
ADROVANCE 70MG/2800IU TBL NOB 6
0027979 EU/1/06/364/003 adrovance.pdf adrovance.pdf M05BB03 R
ADROVANCE 70MG/2800IU TBL NOB 12
0027980 EU/1/06/364/004 adrovance.pdf adrovance.pdf M05BB03 R
ADROVANCE 70MG/5600IU TBL NOB 12
0029661 EU/1/06/364/008 adrovance.pdf adrovance.pdf M05BB03 R
ADROVANCE 70MG/5600IU TBL NOB 4
0029660 EU/1/06/364/007 adrovance.pdf adrovance.pdf M05BB03 R
ADROVANCE 70MG/5600IU TBL NOB 2
0029659 EU/1/06/364/006 adrovance.pdf adrovance.pdf M05BB03 R
ADROVANCE 70MG/2800IU TBL NOB 2
0027977 EU/1/06/364/001 adrovance.pdf adrovance.pdf M05BB03 R

‹‹ ‹ 1 2 3 4 5 6 7 8 10 20 30 40 50 100 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 12. October 2021 at 01:10
Last update of price and payment data: 1. October 2021 at 01:09